Apollo Medical Holdings Announces The Acquisition Of Technology Assets Of Healarium, Inc.

CONTINUES THE GROWTH OF POPULATION HEALTH MANAGEMENT SERVICE OFFERINGS

12 Jan, 2016, 12:35 ET from Apollo Medical Holdings, Inc.

GLENDALE, Calif., Jan. 12, 2016 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (AMEH), an integrated population health management company, is pleased to announce that Apollo Care Connect, a wholly-owned subsidiary of ApolloMed, has acquired the population health management technology and operating platform of Healarium, Inc.  The acquisition expands ApolloMed's medical management and care coordination capabilities and positions the company for further market expansion.

Healarium, founded in 2009, provides a cloud and mobile-based population health management platform, with an emphasis on chronic care management and total patient engagement.  Among its distinctive components are a Care Management Dashboard which allows care managers to quickly focus on high-risk patients, Digital Care Plans which use evidence-based protocols, and a Personal Health Assistant, accessible via mobile or web, that allows patients to view their health data, care plans, receive alerts and to track goal progress.  With one click, physicians and care managers can prescribe patients a clinically appropriate and comprehensive treatment plan. This care plan is personalized and includes daily regimens which leverage ApolloMed's expertise in clinical care, care coordination and medical risk management.  Healarium's platform has reduced expenditures in patients with chronic conditions and also reduced hospital readmissions and emergency room visits.  Additionally, the platform supports the requirements to satisfy the Centers for Medicare and Medicaid Services ("CMS") Chronic Care Management ("CCM") reimbursements for those Medicare enrollees with two or more chronic conditions.  Healarium has the capability to aggregate data from multiple sources, including hospital and physician electronic health records.  Healarium will continue to support Apollo Care Connect's growth.

"We believe that engaging patients in their own care is an important part of the changing landscape of healthcare," stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings, Inc.  "Healarium's technology platform will further enable us to meet the new challenges in the evolving world of value-based reimbursements."

"Combining ApolloMed's clinical expertise and performance-based financial models with a robust chronic care management software platform is a powerful solution to today's healthcare needs," stated Gary Augusta, Executive Chairman of Apollo Medical Holdings, Inc.  "We look forward to working with our existing and future hospital, health plan and medical group partners who are looking to transition to a value-based care model."

About Apollo Medical Holdings, Inc. (ApolloMed)

Headquartered in Glendale, California, ApolloMed is a leading integrated population health management company committed to providing exceptional multi-disciplinary care in the communities it serves.  ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated healthcare delivery platform comprised of six affiliated and complementary physician groups:  ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group, AKM Medical Group, ApolloMed Care Clinics and Apollo Palliative Services. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care.  For more information, please visit www.apollomed.net

Forward Looking Statements

This press release may contain forward-looking statements, including information about management's view of Apollo Medical Holdings, Inc. ("the Company") future expectations, plans and prospects.  In particular, when used in the preceding discussion, the words "believes," "expects," "intends," "plans," "anticipates," or "may," and similar conditional expressions are intended to identify forward-looking statements.  Any statements made in this press release other than those of historical fact, about an action, event or development, are forward-looking statements.  These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of the Company, its subsidiaries and concepts to be materially different than those expressed or implied in such statements.  Unknown or unpredictable factors also could have material adverse effects on the Company's future results. Some factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the Company's Annual Report on our amended Form 10-K for the fiscal year ended March 31, 2015, under the caption "Risk Factors", which is on file with the Securities and Exchange Commission and available in the "Investor" section of the Company's website under the heading "SEC Filings".  The forward-looking statements included in this press release are made only as of the date hereof.  The Company cannot guarantee future results, levels of activity, performance or achievements.  Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by Apollo Medical Holdings, Inc.

For More Information, PLEASE CONTACT:

Michael Sullivan
RedChip Companies Inc.
1-800-733-2447  Ext. 115
michael@redchip.com

 

SOURCE Apollo Medical Holdings, Inc.



RELATED LINKS

http://apollomed.net